“Tumors treated with vanoxerine become more susceptible to attack by the immune system due to the reactivation of ancient viral DNA fragments accumulated in our genome throughout evolution,” explained lead researcher Yannick Benoit, an associate professor of cellular and molecular medicine at the University of Ottowa in Canada., the brain chemical involved in sensations of pleasure and reward. Because of this, it was first developed to help people with an.
Further research will be needed to fully test the ability of vanexorine to slow or stop colon cancer, the researchers added., we profoundly hope our work can lead to the development of powerful options for treatment in the future and substantially increase their survival chances,” Benoit said.SOURCE: University of Ottowa, news release, Feb. 13, 2024Colorectal cancer is the cause of many cancer deaths.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: KTVU - 🏆 465. / 53 Read more »